Follow The Filings

OGN Organon

Organon earnings company data as of 4:47 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS 0.95 — —
Rev — — —

Insider trades

Open-market buys and sales by OGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OGN insider trades
  • $855K bought by 2 insiders
  • $553K sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Juliana Papa Drinane Head of Mfg & Supply
    Sale
    $200K 14,761 shares at $13.57 44% of stake
    Traded Aug 5 Filed Aug 5
    ↗
  2. Lynette Holzbaur SVP and Corporate Controller
    Sale
    $353K 26,448 shares at $13.35 100% of stake
    Traded May 6 Filed May 7
    ↗
  3. Lynette Holzbaur SVP and Corporate Controller
    Buy
    $353K 26,448 shares at $13.35 +100% to stake
    Traded May 6 Filed May 7
    ↗
  4. Carrie Smith Cox Chair
    Buy
    $502K 65,400 shares at $7.67 +525% to stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 46 share withholdings for taxes, 34 option exercises, 12 stock grants, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.